Applying this cell membrane-based biomaterials platform to the potential therapeutic targets found in our study, such as lung epithelial cells, N proteins, IP-10, or other cytokines, will help develop new treatment strategies to prevent the progression of severe COVID-19. The gene discussed is CXCL10; the disease is COVID-19.